1. Home
  2. ISSC vs DCTH Comparison

ISSC vs DCTH Comparison

Compare ISSC & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$16.34

Market Cap

346.6M

Sector

Technology

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$12.20

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISSC
DCTH
Founded
1988
1988
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.6M
372.5M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
ISSC
DCTH
Price
$16.34
$12.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$18.25
$22.00
AVG Volume (30 Days)
374.9K
552.1K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
107.53
EPS
0.41
N/A
Revenue
N/A
N/A
Revenue This Year
$7.95
$24.54
Revenue Next Year
$6.82
$33.15
P/E Ratio
$39.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.13
$8.12
52 Week High
$30.98
$13.72

Technical Indicators

Market Signals
Indicator
ISSC
DCTH
Relative Strength Index (RSI) 41.82 61.50
Support Level $15.07 $10.31
Resistance Level $19.92 $12.34
Average True Range (ATR) 1.07 0.62
MACD 0.02 0.07
Stochastic Oscillator 11.35 91.72

Price Performance

Historical Comparison
ISSC
DCTH

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: